Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Salt Lake City
mi
from
Salt Lake City, UT
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Salt Lake City
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
Swedish Cancer Institute
mi
from
Seattle, WA
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Seattle
mi
from
Seattle, WA
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated:  10/23/2015
CCOP - Northwest
mi
from
Tacoma, WA
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623
Status: Enrolling
Updated: 10/23/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Midwest Center for Hematology/Oncology
mi
from
Joliet, IL
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Midwest Center for Hematology/Oncology
mi
from
Joliet, IL
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
St. John's Regional Health Center
mi
from
Springfield, MO
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Good Samaritan Hospital Cancer Treatment Center
mi
from
Cincinnati, OH
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Good Samaritan Hospital Cancer Treatment Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Bethesda North Hospital
mi
from
Cincinnati, OH
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Tod Children's Hospital
mi
from
Youngstown, OH
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Tod Children's Hospital
mi
from
Youngstown, OH
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Geisinger Medical Center
mi
from
Danville, PA
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Geisinger Medical Group - Scenery Park
mi
from
State College, PA
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated:  10/23/2015
U.T. Cancer Institute at University of Tennessee Medical Center
mi
from
Knoxville, TN
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer
Status: Enrolling
Updated: 10/23/2015
U.T. Cancer Institute at University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Western Regional, Arizona
mi
from
Phoenix, AZ
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Western Regional, Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
mi
from
Phoenix, AZ
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Tucson
mi
from
Tucson, AZ
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Little Rock
mi
from
Little Rock, AR
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Little Rock
mi
from
Little Rock, AR
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
California Cancer Center - Woodward Park Office
mi
from
Fresno, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
California Cancer Center - Woodward Park Office
mi
from
Fresno, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Loma Linda (Pettis)
mi
from
Loma Linda, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Loma Linda (Pettis)
mi
from
Loma Linda, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Outpatient Clinic - Martinez
mi
from
Martinez, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Outpatient Clinic - Martinez
mi
from
Martinez, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
mi
from
Orange, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Santa Rosa Memorial Hospital
mi
from
Santa Rosa, CA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Santa Rosa Memorial Hospital
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Aurora, CO
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Denver
mi
from
Denver, CO
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Denver
mi
from
Denver, CO
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
MBCCOP - Howard University Cancer Center
mi
from
Washington,
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
MBCCOP - Howard University Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Tampa (Haley)
mi
from
Tampa, FL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Tampa (Haley)
mi
from
Tampa, FL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Atlanta Regional
mi
from
Atlanta, GA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Atlanta Regional
mi
from
Atlanta, GA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Central Illinois
mi
from
Decatur, IL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Cardinal Bernardin Cancer Center at Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
CCOP - Wichita
mi
from
Wichita, KA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated:  10/23/2015
Veterans Affairs Medical Center - Wichita
mi
from
Wichita, KA
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
Status: Enrolling
Updated: 10/23/2015
Veterans Affairs Medical Center - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials